Nutex Health Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Nutex Health stock has a consensus rating of "Strong Buy" and an average price target of $235.5. The average 1-year stock price forecast is 76.58% higher than the current stock price, while the lowest is $175 (+31.22%) and the highest is $300 (+124.95%).

Price Target: $235.5 (+76.58%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$175	$235.5	$233.5	$300
Change	+31.22%	+76.58%	+75.08%	+124.95%

Analyst Ratings

The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Nov '25	Dec '25	Mar '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Haynor Lake Street	Lake Street	Buy Initiates $235	Buy	Initiates	$235	+76.21%	Jun 2, 2026
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $175	Buy	Maintains	$175	+31.22%	May 3, 2026
Bill Sutherland Benchmark Co.	Benchmark Co.	Buy Reiterates $300	Buy	Reiterates	$300	+124.95%	Mar 10, 2026

Financial Forecast

Revenue This Year

881.34M

from 875.26M

0.70%

from 875.26M

Revenue Next Year

972.16M

from 881.34M

10.30%

from 881.34M

EPS This Year

19.59

from -

EPS Next Year

20.33

from 19.59

3.78%

from 19.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	331.53M	219.29M	247.65M	479.95M	875.26M	881.34M
Revenue Growth	20.98%	-33.85%	12.93%	93.80%	82.37%	0.70%
Gross Profit	186.94M	28.55M	57.87M	220.83M	471.31M	382.80M
Gross Margin	56.39%	13.02%	23.37%	46.01%	53.85%	43.43%
Operating Income	173.82M	-4.58M	-1.29M	137.78M	392.63M	302.83M
Net Income	132.59M	-424.78M	-45.79M	52.10M	70.79M	155.54M
EPS	-	-	-	-	-	19.59
Forward PE	-	-	-	53.71	9.41	6.81
Free Cash Flow	81.10M	53.40M	472.89K	13.18M	152.81M	8.50M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	908.7M
Avg	881.3M
Low	865.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	3.8%
Avg	0.7%
Low	-1.2%

EPS Forecast

EPS	2026	2027	2028
High	19.59
Avg	19.59
Low	19.59

EPS Growth

EPS Growth	2027	2028
High	3.8%
Avg	3.8%
Low	3.8%